Wrapping Up Clinical Trial 1!

We are excited to report that we have completed our first virtual reality clinical trial with New York Eye & Ear (ClinicalTrials.gov Identifier: NCT04714424). The trial focused on measuring ptosis, or eyelid droop, in an oculoplastic setting and demonstrated that our proprietary exam performed similarly to the expensive in-office standard in a fraction of the time. Patients also preferred our VR test to the in-office machine in terms of speed, comfort, and overall experience!

This is an important step towards integration of VR vision tests into ophthalmic workflows. In order to qualify for insurance reimbursement of a ptosis surgical correction, oculoplastic surgeons have to quantitatively validate that the patient is suffering from a certain level of vision loss. Our test has the potential to make this process much more efficient than the current standards.

We are working closely with a peer-reviewed ophthalmic journal to get this work published! In the meantime, our previous conference abstract on this trial is available here: https://iovs.arvojournals.org/article.aspx?articleid=2768464

Previous
Previous

OcuVue™ Digital Vision Screening Platform: The Series

Next
Next

Invited to Present at Prestigious ARVO 2022 Conference!